Lithium treatment mitigates the diabetogenic effects of chronic cortico-therapy.

[1]  O. Forlenza,et al.  Revisiting global cognitive and functional state 13 years after a clinical trial of lithium for mild cognitive impairment , 2022, Revista brasileira de psiquiatria.

[2]  H. Eldar-Finkelman,et al.  Prospects in GSK-3 Signaling: From Cellular Regulation to Disease Therapy , 2022, Cells.

[3]  M. Korbonits,et al.  Glucose and lipid metabolism abnormalities in Cushing's syndrome , 2022, Journal of neuroendocrinology.

[4]  J. Rybakowski.  Antiviral, immunomodulatory, and neuroprotective effect of lithium. , 2022, Journal of integrative neuroscience.

[5]  S. Tolu,et al.  Underlying mechanisms of glucocorticoid-induced β-cell death and dysfunction: a new role for glycogen synthase kinase 3 , 2021, Cell Death & Disease.

[6]  T. Suppes,et al.  Prevalence of impaired kidney function in patients with long‐term lithium treatment: A systematic review and meta‐analysis , 2021, Bipolar disorders.

[7]  H. Ortsäter,et al.  Coadministration of sitagliptin or metformin has no major impact on the adverse metabolic outcomes induced by dexamethasone treatment in rats. , 2021, Life sciences.

[8]  M. Stathopoulou,et al.  Paternal High-Protein Diet Programs Offspring Insulin Sensitivity in a Sex-Specific Manner , 2021, Biomolecules.

[9]  B. Fève,et al.  Molecular Mechanisms of Glucocorticoid-Induced Insulin Resistance , 2021, International journal of molecular sciences.

[10]  P. Schuetz,et al.  Outcomes of Hospitalized Patients with Glucocorticoid-Induced Hyperglycemia—A Retrospective Analysis , 2020, Journal of clinical medicine.

[11]  P. Cattan,et al.  Implication of glycogen synthase kinase 3 in diabetes-associated islet inflammation. , 2020, The Journal of endocrinology.

[12]  P. Gourdy,et al.  Adaptive β-Cell Neogenesis in the Adult Mouse in Response to Glucocorticoid-Induced Insulin Resistance , 2018, Diabetes.

[13]  P. Ebeling,et al.  Glucocorticoid‐Induced Insulin Resistance in Men Is Associated With Suppressed Undercarboxylated Osteocalcin , 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[14]  F. Ceccato,et al.  Diabetes Mellitus Secondary to Cushing’s Disease , 2018, Front. Endocrinol..

[15]  P. Puigserver,et al.  Insulin regulation of gluconeogenesis , 2018, Annals of the New York Academy of Sciences.

[16]  B. Blazar,et al.  Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy. , 2017, The New England journal of medicine.

[17]  A. Stranahan,et al.  Glucocorticoid-mediated activation of GSK3β promotes tau phosphorylation and impairs memory in type 2 diabetes , 2017, Neurobiology of Aging.

[18]  M. Berk,et al.  Recalibrating the risks and benefits of lithium therapy , 2017, British Journal of Psychiatry.

[19]  L. Rubin,et al.  Subtly Modulating Glycogen Synthase Kinase 3 β: Allosteric Inhibitor Development and Their Potential for the Treatment of Chronic Diseases. , 2017, Journal of medicinal chemistry.

[20]  A. Rafacho,et al.  Impact of Glucocorticoid Excess on Glucose Tolerance: Clinical and Preclinical Evidence , 2016, Metabolites.

[21]  Wei Wang,et al.  Increased Glycogen Synthase Kinase-3β and Hexose-6-Phosphate Dehydrogenase Expression in Adipose Tissue May Contribute to Glucocorticoid-Induced Mouse Visceral Adiposity , 2016, International Journal of Obesity.

[22]  J. Walsh,et al.  Mechanisms underlying the benefits of anticonvulsants over lithium in the treatment of bipolar disorder. , 2016, Neuroreport.

[23]  H. Ortsäter,et al.  Glucocorticoids suppress GLP-1 secretion: possible contribution to their diabetogenic effects. , 2015, Clinical science.

[24]  B. Portha,et al.  Expression of the kynurenine pathway enzymes in the pancreatic islet cells. Activation by cytokines and glucolipotoxicity. , 2015, Biochimica et biophysica acta.

[25]  M. Alda,et al.  Gray-Matter Volume, Midbrain Dopamine D2/D3 Receptors and Drug Craving in Methamphetamine Users , 2015, Molecular Psychiatry.

[26]  I. Quesada,et al.  Glucocorticoid treatment and endocrine pancreas function: implications for glucose homeostasis, insulin resistance and diabetes. , 2014, The Journal of endocrinology.

[27]  Xinglin Shi,et al.  Inhibition of Glycogen Synthase Kinase-3β Attenuates Glucocorticoid-Induced Suppression of Myogenic Differentiation In Vitro , 2014, PloS one.

[28]  S. Taboga,et al.  Pancreatic Alpha-Cell Dysfunction Contributes to the Disruption of Glucose Homeostasis and Compensatory Insulin Hypersecretion in Glucocorticoid-Treated Rats , 2014, PloS one.

[29]  T. Dudev,et al.  Wnt and lithium: a common destiny in the therapy of nervous system pathologies? , 2014, Cellular and Molecular Life Sciences.

[30]  R. Weiss,et al.  Steroid‐induced diabetes: a clinical and molecular approach to understanding and treatment , 2014, Diabetes/metabolism research and reviews.

[31]  J. Dougherty,et al.  Lithium protects against glucocorticoid induced neural progenitor cell apoptosis in the developing cerebellum , 2014, Brain Research.

[32]  J. Thissen,et al.  Glucocorticoid-induced skeletal muscle atrophy. , 2013, The international journal of biochemistry & cell biology.

[33]  S. Atamanalp,et al.  Protective effects of lithium: a new look at an old drug with potential antioxidative and anti-inflammatory effects in an animal model of sepsis. , 2013, International immunopharmacology.

[34]  B. Portha,et al.  Local in vivo GSK3β knockdown promotes pancreatic β cell and acinar cell regeneration in 90% pancreatectomized rat. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[35]  M. Birnbaum,et al.  Insulin signaling to hepatic lipid metabolism in health and disease , 2011, Critical reviews in biochemistry and molecular biology.

[36]  D. Ouwens,et al.  Glucagon-Like Peptide-1 Receptor Agonist Treatment Prevents Glucocorticoid-Induced Glucose Intolerance and Islet-Cell Dysfunction in Humans , 2011, Diabetes Care.

[37]  Ronit Vogt Sionov,et al.  Glycogen synthase kinase-3 plays a central role in mediating glucocorticoid-induced apoptosis. , 2010, Molecular endocrinology.

[38]  R. Heine,et al.  Acute and 2-week exposure to prednisolone impair different aspects of beta-cell function in healthy men. , 2010, European journal of endocrinology.

[39]  Ilsoo Kim,et al.  Mechanism of potassium-channel selectivity revealed by Na+ and Li+ binding sites within the KcsA pore , 2009, Nature Structural &Molecular Biology.

[40]  J. Lazarus.  Lithium and thyroid. , 2009, Best practice & research. Clinical endocrinology & metabolism.

[41]  E. Brown.  Effects of Glucocorticoids on Mood, Memory, and the Hippocampus , 2009, Annals of the New York Academy of Sciences.

[42]  D. Ouwens,et al.  Novel insights into glucocorticoid‐mediated diabetogenic effects: towards expansion of therapeutic options? , 2009, European journal of clinical investigation.

[43]  P. Andersen,et al.  Lithium treatment and risk of dementia. , 2008, Archives of general psychiatry.

[44]  J. Burén,et al.  Insulin action and signalling in fat and muscle from dexamethasone-treated rats. , 2008, Archives of biochemistry and biophysics.

[45]  B. Walker,et al.  Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome. , 2008, The Journal of endocrinology.

[46]  K. Saag,et al.  The epidemiology of glucocorticoid-associated adverse events , 2008, Current opinion in rheumatology.

[47]  R. Jope,et al.  Glycogen Synthase Kinase-3 (GSK3): Inflammation, Diseases, and Therapeutics , 2007, Neurochemical Research.

[48]  E. Henriksen,et al.  Essential role of p38 MAPK for activation of skeletal muscle glucose transport by lithium , 2007, Archives of physiology and biochemistry.

[49]  H. Cohen,et al.  Glucocorticoids Regulate Transcription of the Gene for Phosphoenolpyruvate Carboxykinase in the Liver via an Extended Glucocorticoid Regulatory Unit* , 2005, Journal of Biological Chemistry.

[50]  D. Alexander,et al.  Serum- and glucocorticoid-inducible kinase 1 (SGK1) mediates glucocorticoid-induced inhibition of insulin secretion. , 2005, Diabetes.

[51]  C. Ostenson,et al.  Aged transgenic mice with increased glucocorticoid sensitivity in pancreatic beta-cells develop diabetes. , 2004, Diabetes.

[52]  Kirk W. Johnson,et al.  Modulation of muscle insulin resistance by selective inhibition of GSK-3 in Zucker diabetic fatty rats. , 2003, American journal of physiology. Endocrinology and metabolism.

[53]  G. Coetzee,et al.  Glucocorticoids Inhibit Cell Cycle Progression in Differentiating Osteoblasts via Glycogen Synthase Kinase-3β* , 2002, The Journal of Biological Chemistry.

[54]  H. Eldar-Finkelman,et al.  Glycogen synthase kinase 3: an emerging therapeutic target. , 2002, Trends in molecular medicine.

[55]  G. Schrauzer.  Lithium: Occurrence, Dietary Intakes, Nutritional Essentiality , 2002, Journal of the American College of Nutrition.

[56]  J. Lesage,et al.  Glucocorticoids impair fetal β-cell development in rats , 2001 .

[57]  A. Harwood,et al.  Lithium inhibits glycogen synthase kinase-3 by competition for magnesium. , 2001, Biochemical and biophysical research communications.

[58]  O. Shah,et al.  Glucocorticoids oppose translational control by leucine in skeletal muscle. , 2000, American journal of physiology. Endocrinology and metabolism.

[59]  F. Bryant,et al.  Li+/Mg2+ competition at therapeutic intracellular Li+ levels in human neuroblastoma SH-SY5Y cells. , 2000, Bipolar disorders.

[60]  H. Williams,et al.  Topical corticosteroid phobia in patients with atopic eczema , 2000, The British journal of dermatology.

[61]  L. Tappy,et al.  Effects of dexamethasone on hepatic glucose production and fructose metabolism in healthy humans. , 1997, The American journal of physiology.

[62]  J. Gies,et al.  Glucocorticoid modulation of muscarinic and β‐adrenergic receptors in guinea pig lung , 1997, Fundamental & clinical pharmacology.

[63]  P. Gilon,et al.  Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets. , 1997, The Journal of clinical investigation.

[64]  G. Dimitriadis,et al.  Effects of glucocorticoid excess on the sensitivity of glucose transport and metabolism to insulin in rat skeletal muscle. , 1997, The Biochemical journal.

[65]  D. Melton,et al.  A molecular mechanism for the effect of lithium on development. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[66]  G. Sesti,et al.  Quantitative analysis of pancreatic glucokinase gene expression in cultured β cells by competitive polymerase chain reaction , 1996, Molecular and Cellular Endocrinology.

[67]  P. Cohen,et al.  Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B , 1995, Nature.

[68]  P. Vollenweider,et al.  Mechanisms of dexamethasone-induced insulin resistance in healthy humans. , 1994, The Journal of clinical endocrinology and metabolism.

[69]  A. Lange,et al.  Isolation of a cDNA for the catalytic subunit of rat liver glucose-6-phosphatase: regulation of gene expression in FAO hepatoma cells by insulin, dexamethasone and cAMP. , 1994, Biochemical and biophysical research communications.

[70]  C. Kahn,et al.  Modulation of insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of dexamethasone-treated rats. , 1993, The Journal of clinical investigation.

[71]  J. Eisman,et al.  Role of the negative glucocorticoid regulatory element in glucocorticoid repression of the human osteocalcin promoter , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[72]  I. Valverde,et al.  Hyperglucagonism induced by glucocorticoid treatment in man. , 1973, The New England journal of medicine.

[73]  O. Michael,et al.  Enhanced hepatic glycogen synthesis and suppressed adenosine deaminase activity by lithium attenuates hepatic triglyceride accumulation in nicotine-exposed rats. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[74]  Å. Sjöholm,et al.  b -cell adaptation in a mouse model of glucocorticoid-induced metabolic syndrome , 2013 .

[75]  Richard R Almon,et al.  Glucocorticoid effects on adiponectin expression. , 2012, Vitamins and hormones.

[76]  S. Taboga,et al.  Glucocorticoids in vivo induce both insulin hypersecretion and enhanced glucose sensitivity of stimulus-secretion coupling in isolated rat islets. , 2010, Endocrinology.

[77]  B. Gajkowska,et al.  Delineation of signalling pathway leading to antioxidant-dependent inhibition of dexamethasone-mediated muscle cell death , 2004, Journal of Muscle Research & Cell Motility.

[78]  J. Collins,et al.  Glycogen Synthase Kinase 3β-Mediated Serine Phosphorylation of the Human Glucocorticoid Receptor Redirects Gene Expression Profiles , 2008, Molecular and Cellular Biology.